Aligos therapeutics to present at the h.c. wainwright 27th annual global investment conference

South san francisco, calif., sept. 02, 2025 (globe newswire) -- aligos therapeutics, inc. (nasdaq: algs) a clinical stage biopharmaceutical company focused on improving patient outcomes through best-in-class therapies for liver and viral diseases, today announced that members of management will present at the h.c. wainwright 27th annual global investment conference being held september 8-10, 2025.
ALGS Ratings Summary
ALGS Quant Ranking